The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 347:948 September 19, 2002 Number 12
NextNext

Aspirin for the Primary Prevention of Coronary Events

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Lauer, M. S.
-PubMed Citation
To the Editor: In his Clinical Practice article on aspirin for the primary prevention of coronary events (May 9 issue),1 Dr. Lauer notes that diabetes is associated with a significant risk of fatal and nonfatal coronary heart disease. He reviews data on the use of aspirin in the primary prevention of cardiac events in patients with diabetes.2,3 However, he does not take the presence of diabetes into account in calculating the risk of coronary events. A recent meta-analysis by the Antithrombotic Trialists' Collaboration4 provides support for the prophylactic use of aspirin in patients with diabetes. There is no evidence to . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.